Rosen M I, Rosenheck R
Department of Psychiatry, Yale University School of Medicine, Connecticut-Massachusetts Veterans Affairs Mental Illness Clinical Research and Education Center, USA.
Psychiatr Serv. 1999 Jan;50(1):95-8. doi: 10.1176/ps.50.1.95.
Recent legislation prohibiting the awarding of Social Security Disability Insurance benefits to people whose disability is based on drug and alcohol abuse has effectively eliminated the Social Security Administration's practice of assigning representative payees to such persons. Currently no regulations exist for assigning representative payees to substance users who receive benefits based on non-substance-use disabilities. The authors suggest guidelines for determining when recipients with comorbid substance use disorders are incapable of managing their benefit funds. Representative payeeship is recommended for recipients who meet three criteria within the last 12 months: a maladaptive pattern of substance use; mismanagement of funds due to substance use, causing substantial harm to the recipient, unavailability of sufficient funds to meet basic needs, or victimization of the recipient; and availability of a representative payee whose efforts would increase the likelihood that the beneficiary's mismanagement of funds will be curtailed.
最近的立法禁止向因药物和酒精滥用导致残疾的人发放社会保障残疾保险福利，这实际上消除了社会保障管理局为这类人指定受托人的做法。目前，对于因非药物使用残疾而领取福利的药物使用者，不存在指定受托人的相关规定。作者提出了一些指导方针，用于确定患有共病药物使用障碍的受益人何时无能力管理其福利资金。对于在过去12个月内符合以下三项标准的受益人，建议指定受托人：药物使用的适应不良模式；因药物使用导致资金管理不善，对受益人造成重大伤害、资金不足以满足基本需求或使受益人成为受害者；有受托人存在，其努力将增加减少受益人资金管理不善情况的可能性。
